Characteristics of new referrals to twenty-seven lymphoedema treatment units.
Identifieur interne : 004D39 ( PubMed/Curation ); précédent : 004D38; suivant : 004D40Characteristics of new referrals to twenty-seven lymphoedema treatment units.
Auteurs : J. Sitzia [Royaume-Uni] ; M. Woods ; P. Hine ; A. Williams ; K. Eaton ; G. GreenSource :
- European journal of cancer care [ 0961-5423 ] ; 1998.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Angleterre (épidémiologie), Enfant, Enquêtes et questionnaires, Femelle, Humains, Lymphoedème (), Lymphoedème (épidémiologie), Lymphoedème (étiologie), Mâle, Orientation vers un spécialiste (utilisation), Pays de Galles (épidémiologie), Prévalence, Répartition par âge, Service hospitalier d'oncologie (utilisation), Sujet âgé, Sujet âgé de 80 ans ou plus, Tumeurs (), Unités hospitalières (utilisation), Études prospectives.
- MESH :
- utilisation : Orientation vers un spécialiste, Service hospitalier d'oncologie, Unités hospitalières.
- épidémiologie : Angleterre, Lymphoedème, Pays de Galles.
- étiologie : Lymphoedème.
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Enquêtes et questionnaires, Femelle, Humains, Lymphoedème, Mâle, Prévalence, Répartition par âge, Sujet âgé, Sujet âgé de 80 ans ou plus, Tumeurs, Études prospectives.
English descriptors
- KwdEn :
- Adolescent, Adult, Age Distribution, Aged, Aged, 80 and over, Child, England (epidemiology), Female, Hospital Units (utilization), Humans, Lymphedema (epidemiology), Lymphedema (etiology), Lymphedema (therapy), Male, Middle Aged, Neoplasms (complications), Oncology Service, Hospital (utilization), Prevalence, Prospective Studies, Referral and Consultation (utilization), Surveys and Questionnaires, Wales (epidemiology).
- MESH :
- geographic , epidemiology : England, Wales.
- complications : Neoplasms.
- epidemiology : Lymphedema.
- etiology : Lymphedema.
- therapy : Lymphedema.
- utilization : Hospital Units, Oncology Service, Hospital, Referral and Consultation.
- Adolescent, Adult, Age Distribution, Aged, Aged, 80 and over, Child, Female, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Surveys and Questionnaires.
Abstract
Lymphoedema affects 25-28% of patients who have undergone axillary surgery or radiotherapy in the treatment of cancer. The prevalence of primary lymphoedema or of lymphoedema secondary to non-cancer causes is unknown. In addition, basic demographic and disease characteristics of the lymphoedema population remain undocumented. We conducted a prospective survey to determine these characteristics. Lymphoedema treatment clinics in the UK were invited to participate at the British Lymphology Society 1996 Annual Conference. Twenty-seven clinics collected a standard data set for all new referrals in a 3-month period in 1997. The sample size was 603. The mean number of new referrals was 7.4 patients per unit per month. Eighty per cent of patients had cancer-related lymphoedema, and 86% of patients were female. Patients' mean age was 61.0 years. Thirty-seven per cent of the sample had suffered lymphoedema for less than 3 months, and 15% for 5 years or more. Patients with non-cancer related oedema had suffered the condition disproportionately longer than the cancer-related group (chi 2 = 102.2, P < 0.001). Sixty-six per cent of patients were reported as having lymphoedema at more than one site. Seventy-four per cent of all patients suffered unilateral limb oedema, and 23% bilateral limb oedema. Bilateral swelling was recorded for 67% of the non-cancer related group and 13% of the cancer related group (chi 2 = 153.4, P < 0.001). Median percentage excess volume (PCEV) for all patients with unilateral limb oedema was 16.4%. There was a positive relationship between PCEV and duration of the condition (H = 24.0, P < 0.001), and PCEV and non-cancer related lymphoedema (H = 10.5, P < 0.05). These results suggest that patients with non-cancer related lymphoedema and those with cancer-related lymphoedema form two distinct groups. The former present substantial management problems which are made more complex by late referral.
PubMed: 9919113
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004D39
Links to Exploration step
pubmed:9919113Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Characteristics of new referrals to twenty-seven lymphoedema treatment units.</title><author><name sortKey="Sitzia, J" sort="Sitzia, J" uniqKey="Sitzia J" first="J" last="Sitzia">J. Sitzia</name><affiliation wicri:level="1"><nlm:affiliation>Worthing and Southlands Hospitals NHS Trust, Worthing Hospital, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Worthing and Southlands Hospitals NHS Trust, Worthing Hospital</wicri:regionArea></affiliation></author><author><name sortKey="Woods, M" sort="Woods, M" uniqKey="Woods M" first="M" last="Woods">M. Woods</name></author><author><name sortKey="Hine, P" sort="Hine, P" uniqKey="Hine P" first="P" last="Hine">P. Hine</name></author><author><name sortKey="Williams, A" sort="Williams, A" uniqKey="Williams A" first="A" last="Williams">A. Williams</name></author><author><name sortKey="Eaton, K" sort="Eaton, K" uniqKey="Eaton K" first="K" last="Eaton">K. Eaton</name></author><author><name sortKey="Green, G" sort="Green, G" uniqKey="Green G" first="G" last="Green">G. Green</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1998">1998</date><idno type="RBID">pubmed:9919113</idno><idno type="pmid">9919113</idno><idno type="wicri:Area/PubMed/Corpus">004D39</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004D39</idno><idno type="wicri:Area/PubMed/Curation">004D39</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004D39</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Characteristics of new referrals to twenty-seven lymphoedema treatment units.</title><author><name sortKey="Sitzia, J" sort="Sitzia, J" uniqKey="Sitzia J" first="J" last="Sitzia">J. Sitzia</name><affiliation wicri:level="1"><nlm:affiliation>Worthing and Southlands Hospitals NHS Trust, Worthing Hospital, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Worthing and Southlands Hospitals NHS Trust, Worthing Hospital</wicri:regionArea></affiliation></author><author><name sortKey="Woods, M" sort="Woods, M" uniqKey="Woods M" first="M" last="Woods">M. Woods</name></author><author><name sortKey="Hine, P" sort="Hine, P" uniqKey="Hine P" first="P" last="Hine">P. Hine</name></author><author><name sortKey="Williams, A" sort="Williams, A" uniqKey="Williams A" first="A" last="Williams">A. Williams</name></author><author><name sortKey="Eaton, K" sort="Eaton, K" uniqKey="Eaton K" first="K" last="Eaton">K. Eaton</name></author><author><name sortKey="Green, G" sort="Green, G" uniqKey="Green G" first="G" last="Green">G. Green</name></author></analytic><series><title level="j">European journal of cancer care</title><idno type="ISSN">0961-5423</idno><imprint><date when="1998" type="published">1998</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Distribution</term><term>Aged</term><term>Aged, 80 and over</term><term>Child</term><term>England (epidemiology)</term><term>Female</term><term>Hospital Units (utilization)</term><term>Humans</term><term>Lymphedema (epidemiology)</term><term>Lymphedema (etiology)</term><term>Lymphedema (therapy)</term><term>Male</term><term>Middle Aged</term><term>Neoplasms (complications)</term><term>Oncology Service, Hospital (utilization)</term><term>Prevalence</term><term>Prospective Studies</term><term>Referral and Consultation (utilization)</term><term>Surveys and Questionnaires</term><term>Wales (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Angleterre (épidémiologie)</term><term>Enfant</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Lymphoedème ()</term><term>Lymphoedème (épidémiologie)</term><term>Lymphoedème (étiologie)</term><term>Mâle</term><term>Orientation vers un spécialiste (utilisation)</term><term>Pays de Galles (épidémiologie)</term><term>Prévalence</term><term>Répartition par âge</term><term>Service hospitalier d'oncologie (utilisation)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tumeurs ()</term><term>Unités hospitalières (utilisation)</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>England</term><term>Wales</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="utilisation" xml:lang="fr"><term>Orientation vers un spécialiste</term><term>Service hospitalier d'oncologie</term><term>Unités hospitalières</term></keywords><keywords scheme="MESH" qualifier="utilization" xml:lang="en"><term>Hospital Units</term><term>Oncology Service, Hospital</term><term>Referral and Consultation</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Angleterre</term><term>Lymphoedème</term><term>Pays de Galles</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Distribution</term><term>Aged</term><term>Aged, 80 and over</term><term>Child</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prevalence</term><term>Prospective Studies</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enfant</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Lymphoedème</term><term>Mâle</term><term>Prévalence</term><term>Répartition par âge</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tumeurs</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphoedema affects 25-28% of patients who have undergone axillary surgery or radiotherapy in the treatment of cancer. The prevalence of primary lymphoedema or of lymphoedema secondary to non-cancer causes is unknown. In addition, basic demographic and disease characteristics of the lymphoedema population remain undocumented. We conducted a prospective survey to determine these characteristics. Lymphoedema treatment clinics in the UK were invited to participate at the British Lymphology Society 1996 Annual Conference. Twenty-seven clinics collected a standard data set for all new referrals in a 3-month period in 1997. The sample size was 603. The mean number of new referrals was 7.4 patients per unit per month. Eighty per cent of patients had cancer-related lymphoedema, and 86% of patients were female. Patients' mean age was 61.0 years. Thirty-seven per cent of the sample had suffered lymphoedema for less than 3 months, and 15% for 5 years or more. Patients with non-cancer related oedema had suffered the condition disproportionately longer than the cancer-related group (chi 2 = 102.2, P < 0.001). Sixty-six per cent of patients were reported as having lymphoedema at more than one site. Seventy-four per cent of all patients suffered unilateral limb oedema, and 23% bilateral limb oedema. Bilateral swelling was recorded for 67% of the non-cancer related group and 13% of the cancer related group (chi 2 = 153.4, P < 0.001). Median percentage excess volume (PCEV) for all patients with unilateral limb oedema was 16.4%. There was a positive relationship between PCEV and duration of the condition (H = 24.0, P < 0.001), and PCEV and non-cancer related lymphoedema (H = 10.5, P < 0.05). These results suggest that patients with non-cancer related lymphoedema and those with cancer-related lymphoedema form two distinct groups. The former present substantial management problems which are made more complex by late referral.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">9919113</PMID><DateCreated><Year>2000</Year><Month>02</Month><Day>17</Day></DateCreated><DateCompleted><Year>2000</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0961-5423</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>4</Issue><PubDate><Year>1998</Year><Month>Dec</Month></PubDate></JournalIssue><Title>European journal of cancer care</Title><ISOAbbreviation>Eur J Cancer Care (Engl)</ISOAbbreviation></Journal><ArticleTitle>Characteristics of new referrals to twenty-seven lymphoedema treatment units.</ArticleTitle><Pagination><MedlinePgn>255-62</MedlinePgn></Pagination><Abstract><AbstractText>Lymphoedema affects 25-28% of patients who have undergone axillary surgery or radiotherapy in the treatment of cancer. The prevalence of primary lymphoedema or of lymphoedema secondary to non-cancer causes is unknown. In addition, basic demographic and disease characteristics of the lymphoedema population remain undocumented. We conducted a prospective survey to determine these characteristics. Lymphoedema treatment clinics in the UK were invited to participate at the British Lymphology Society 1996 Annual Conference. Twenty-seven clinics collected a standard data set for all new referrals in a 3-month period in 1997. The sample size was 603. The mean number of new referrals was 7.4 patients per unit per month. Eighty per cent of patients had cancer-related lymphoedema, and 86% of patients were female. Patients' mean age was 61.0 years. Thirty-seven per cent of the sample had suffered lymphoedema for less than 3 months, and 15% for 5 years or more. Patients with non-cancer related oedema had suffered the condition disproportionately longer than the cancer-related group (chi 2 = 102.2, P < 0.001). Sixty-six per cent of patients were reported as having lymphoedema at more than one site. Seventy-four per cent of all patients suffered unilateral limb oedema, and 23% bilateral limb oedema. Bilateral swelling was recorded for 67% of the non-cancer related group and 13% of the cancer related group (chi 2 = 153.4, P < 0.001). Median percentage excess volume (PCEV) for all patients with unilateral limb oedema was 16.4%. There was a positive relationship between PCEV and duration of the condition (H = 24.0, P < 0.001), and PCEV and non-cancer related lymphoedema (H = 10.5, P < 0.05). These results suggest that patients with non-cancer related lymphoedema and those with cancer-related lymphoedema form two distinct groups. The former present substantial management problems which are made more complex by late referral.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sitzia</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Worthing and Southlands Hospitals NHS Trust, Worthing Hospital, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woods</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hine</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Eaton</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>G</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Cancer Care (Engl)</MedlineTA><NlmUniqueID>9301979</NlmUniqueID><ISSNLinking>0961-5423</ISSNLinking></MedlineJournalInfo><CitationSubset>N</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006757" MajorTopicYN="N">Hospital Units</DescriptorName><QualifierName UI="Q000656" MajorTopicYN="Y">utilization</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016522" MajorTopicYN="N">Oncology Service, Hospital</DescriptorName><QualifierName UI="Q000656" MajorTopicYN="Y">utilization</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName><QualifierName UI="Q000656" MajorTopicYN="Y">utilization</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014852" MajorTopicYN="N" Type="Geographic">Wales</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>1</Month><Day>27</Day><Hour>3</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>2</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1999</Year><Month>1</Month><Day>27</Day><Hour>3</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9919113</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004D39 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 004D39 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:9919113
|texte= Characteristics of new referrals to twenty-seven lymphoedema treatment units.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:9919113" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |